Semler to Participate in the Raymond James Human Health Innovation Conference
06/10/2021 - 08:03 AM
SANTA CLARA, Calif. , June 10, 2021 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief marketing officer, Dennis Rosenberg , will present a company overview at the Raymond James Human Health Innovation Conference on Tuesday, June 22 , at 12:00 pm ET .
A live webcast will be available under "Events and Presentations" on the "Investor Info" section of the Semler Scientific website and may be accessed through the following link: https://kvgo.com/rj-health/semler-scientific-inc-june-2021 . The presentation will be archived for a period of 90 days after the conference.
About Semler Scientific, Inc.:
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative proprietary products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and U.S. Food and Drug Administration, or FDA, cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at www.semlerscientific.com .
CONTACT: Susan A. Noonan susan@sanoonan.com
http://www.prnewswire.com/news-releases/semler-to-participate-in-the-raymond-james-human-health-innovation-conference-301309788.html
SOURCE Semler Scientific, Inc.
SMLR Rankings
#4059 Ranked by Stock Gains
SMLR Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
San Jose
About SMLR
semler scientific, inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care. semler closed the initial public offering of its common stock on february 26, 2014 and its common stock is now listed under the ticker symbol "smlr." additional information about semler can be found at www.semlerscientific.com.
